Chemical industry – Page 63
-
Business
Mexico approves world’s first dengue vaccine
Sanofi’s vaccine protects children and adults against the mosquito-borne disease
-
Business
BioAtla and Pfizer to collaborate on antibody research
Two-way agreement to share technology and royalties on new cancer drugs
-
Business
Dow and DuPont mega-merger heralds break-up of giants
New firm will split itself in speciality, agrichemical and materials businesses with R&D taking a hit from cost savings
-
Business
Heptares takes on new partners for drug discovery
Firm set to receive over $1bn from research partnerships
-
Business
Pfizer to close Cambridge pain outpost
120 jobs under threat from closure of Neusentis subsidiary R&D site
-
Business
Perrigo nabs US rights to AZ Crohn’s drug
Irish generics maker evades Mylan takeover bid and expands gastroenterology portfolio
-
Business
Indian chemical factory accident kills four
Fatal explosion at private aluminium powder factory
-
News
Pfizer’s response to compound fraud spotlights quality issues
‘Bosutinib isomer’ typifies threat posed by evolution of chemical supply chain
-
Business
Dow ditches older herbicides
Gowan will acquire Dow’s entire dinitroaniline herbicide portfolio
-
Business
EPA acts to halt approval of Dow’s Enlist Duo herbicide
US environmental agency wants registration of controversial herbicide halted, pending review of new toxicity data
-
News
US agencies test less than 1% of chemicals
Only 250 of the 84,000 chemicals registered for commercial use in the US have been tested by government agencies
-
Business
Merger creates new gases giant
Air Liquide will buy Airgas in a $13 billion deal to become the world’s biggest industrial gases supplier
-
Business
Pfizer and Allergan agree mega-merger
$160 billion deal allows Pfizer to escape US tax system by re-homing in Ireland